BE887639A - Compositions pharmaceutiques pour le traitement de l'hyperplasie prostatique benigne - Google Patents

Compositions pharmaceutiques pour le traitement de l'hyperplasie prostatique benigne

Info

Publication number
BE887639A
BE887639A BE0/203889A BE203889A BE887639A BE 887639 A BE887639 A BE 887639A BE 0/203889 A BE0/203889 A BE 0/203889A BE 203889 A BE203889 A BE 203889A BE 887639 A BE887639 A BE 887639A
Authority
BE
Belgium
Prior art keywords
treatment
pharmaceutical compositions
benign prostatic
prostatic hyperplasia
hyperplasia
Prior art date
Application number
BE0/203889A
Other languages
English (en)
Inventor
C Auclair
Original Assignee
Ayerst Mckenna & Harrison
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayerst Mckenna & Harrison filed Critical Ayerst Mckenna & Harrison
Publication of BE887639A publication Critical patent/BE887639A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE0/203889A 1980-05-22 1981-02-23 Compositions pharmaceutiques pour le traitement de l'hyperplasie prostatique benigne BE887639A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/152,241 US4321260A (en) 1980-05-22 1980-05-22 Method of using gonadorelin for the treatment of benign prostatic hyperplasia

Publications (1)

Publication Number Publication Date
BE887639A true BE887639A (fr) 1981-08-24

Family

ID=22542095

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/203889A BE887639A (fr) 1980-05-22 1981-02-23 Compositions pharmaceutiques pour le traitement de l'hyperplasie prostatique benigne

Country Status (2)

Country Link
US (1) US4321260A (fr)
BE (1) BE887639A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632979A (en) * 1984-06-18 1986-12-30 Tulane Educational Fund Therapeutic LHRH analogs
US4880626A (en) * 1985-01-18 1989-11-14 Mcmichael John Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome
US4970071A (en) * 1985-01-18 1990-11-13 Mcmichael John Immunotherapeutic methods and compositions employing antigens characteristic of non human malignant neoplasms
US4689222A (en) 1985-01-18 1987-08-25 Mcmichael John Methods and materials for alleviation of pain symptoms of malignant neoplasia
US4966753A (en) * 1987-08-18 1990-10-30 Molecular Rx, Inc. Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
WO1991004040A1 (fr) * 1989-09-15 1991-04-04 Biomeasure, Inc. Traitement de cancer du colon
US5610136A (en) * 1996-01-30 1997-03-11 Milkhaus Laboratory, Inc. Method for treatment of benign prostatic hypertrophy
EP2190450A2 (fr) * 2007-09-11 2010-06-02 Mondobiotech Laboratories AG Utilisation de l'hormone de concentration de la mélanine et de la met-enkephaline comme agents thérapeutiques
WO2010033240A2 (fr) 2008-09-19 2010-03-25 Nektar Therapeutics Polymères à base de glucide pour administration de médicaments et leurs conjugués

Also Published As

Publication number Publication date
US4321260A (en) 1982-03-23

Similar Documents

Publication Publication Date Title
BE875634A (fr) Compositions pharmaceutiques et leur utilisation pour le traitement prophylactique et therapeutique de l'hyperplasie de la prostate
BE854414A (fr) Compositions pharmaceutiques pour le traitement de l'hypertrophie benigne de la prostate
BE890648A (fr) Compositions pour le traitement de l'acne
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
BE859817A (fr) Compositions notamment utiles pour le traitement de l'acne
OA06599A (fr) Procédé de préparation d'un agent pour le traitement de théilérioses.
BE865156A (fr) Compositions pharmaceutiques pour le traitement des depressions
BE837662A (fr) Composition gelifiee contenant de la tretinoine pour le traitement de l'acne
BE890433A (fr) Composition cosmetique pour le traitement local de la cellulite
BE887639A (fr) Compositions pharmaceutiques pour le traitement de l'hyperplasie prostatique benigne
BE873092A (fr) Composition pour le traitement de l'hypertension
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
BE829859A (fr) Procedes et compositions pharmaceutiques pour le traitement de l'hypercholesterolemie
BE885291A (fr) Compositions pharmaceutiques pour le traitement des dysfonctionnements cardiaques
FR2558372B1 (fr) Composition medicamenteuse pour le traitement de l'acne
MA20655A1 (fr) Compositions pour le traitement de textiles
BE885290A (fr) Compositions pharmaceutiques pour le traitement des hyperlipidemies et des hyperlipoproteinemies
BE858692A (fr) Composition pour le traitement de l'acne
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
FR2332965A1 (fr) Formulations d'uree-polyphosphate-potassium pour le traitement du feuillage
BE894228A (fr) Composition pharmaceutique pour le traitement de l'atherosclerose
RO79428A2 (fr) Composition medicamenteuse pour le traitement des dermatoses
FR2517203B1 (fr) Composition pour le traitement de l'acne
BE842389A (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
BE869248A (fr) Compositions pharmaceutiques pour le traitement de l'hyperglucagonemie et/ou de l'hyperglycemie

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: AYERST MCKENNA & HARRISON INC.

Effective date: 19840223